Novo Nordisk commits $2.3bn for expansion of Danish API production plant

Novo Nordisk, a Danish pharmaceutical firm, has declared its intention to funnel DKK 15.9 billion ($2.3 billion) into expanding an existing Active Pharmaceutical Ingredient (API) ... Read More